Study of Aripiprazole in Subjects With Alcoholism

Otsuka

Status and phase: Completed; Phase 4

Conditions: Alcoholism

Treatments: Drug: Placebo; Drug: Aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00082199

CN138-089

Details and patient eligibility

About

The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo. The safety of using aripiprazole will also be studied.

Sex: All

Ages: 21 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Subjects with a diagnosis of alcohol dependence who want to stop using alcohol will be considered for the study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

400 participants in 2 patient groups, including a placebo group

A1

Active Comparator group

Treatment:

Drug: Aripiprazole

A2

Placebo Comparator group

Treatment:

Drug: Placebo